CSPC Pharmaceutical Group Limited (CSPCY)
OTCMKTS
· Delayed Price · Currency is USD
4.020
-0.111 (-2.68%)
Jun 26, 2025, 3:09 PM EDT
CSPC Pharmaceutical Group Employees
CSPC Pharmaceutical Group had 21,400 employees as of December 31, 2024. The number of employees decreased by 2,100 or -8.94% compared to the previous year.
Employees
21,400
Change (1Y)
-2,100
Growth (1Y)
-8.94%
Revenue / Employee
$174,135
Profits / Employee
$27,002
Market Cap
11.26B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 21,400 | -2,100 | -8.94% |
Dec 31, 2023 | 23,500 | -1,337 | -5.38% |
Dec 31, 2022 | 24,837 | 91 | 0.37% |
Dec 31, 2021 | 24,746 | 3,219 | 14.95% |
Dec 31, 2020 | 21,527 | 4,227 | 24.43% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Endo, Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Tian'an Technology Group | 8 |
American Oncology Network | 1,914 |
CytoDyn | 9 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
Silence Therapeutics | 116 |
CSPC Pharmaceutical Group News
- 13 days ago - AstraZeneca Inks China AI Research Deal For Chronic Diseases - NDTV
- 13 days ago - AstraZeneca Inks Research Pact With China's CSPC Pharmaceuticals Focused On AI-Driven Research, Valued Up To $5.33 Billion - Benzinga
- 14 days ago - AstraZeneca signs US$5 billion research deal with China’s CSPC - BNN Bloomberg
- 15 days ago - CSPC Pharma Pursues Licensing Deals After Lackluster Earnings - Benzinga
- 4 weeks ago - Chinese biotech’s mega drug-licensing deals with multinationals surge - South China Morning Post
- 8 months ago - CSPC Pharmaceutical Group Limited goes ex dividend tomorrow - Seeking Alpha
- 9 months ago - AstraZeneca Inks Agreement to Boost Cardiovascular Pipeline - Benzinga
- 9 months ago - Dow Tumbles Over 400 Points; Duckhorn Portfolio Shares Surge - Benzinga